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Interactions of (-)-ilimaquinone with methylation enzymes: 
implications for vesicular-mediated secretion 
Heike S Radeke*, Cheryl A Digits? Rebecca L Casaubon and Marc L Snapper 
Background: The marine sponge metabolite (-)-ilimaquinone has antimicrobial, 
anti-HIV, anti-inflammatory and antimitotic activities, inhibits the cytotoxicity of 
ricin and diptheria toxin, and selectively fragments the Golgi apparatus. The 
range of activities demonstrated by this natural product provides a unique 
opportunity for studying these cellular processes. 
Results: Affinity chromatography experiments show that (-)-ilimaquinone 
interacts with enzymes of the activated methyl cycle: S-adenosylmethionine 
synthetase, S-adenosylhomocysteinase and methyl transferases. Known 
inhibitors of these enzymes were found to block vesicle-mediated secretion in a 
manner similar to (-)-ilimaquinone. Moreover, the antisecretory effects of 
(-)-ilimaquinone and inhibitors of methylation chemistry, but not brefeldin A, 
could be reversed in the presence of the cellular methylating agent 
S-adenosylmethionine. Of the enzymes examined in the activated methyl cycle, 
S-adenosylhomocysteinase was specifically inhibited by (-)-ilimaquinone. 
Consistent with these observations, (-)-ilimaquinone was shown to obstruct 
new methylation events in adrenocorticotrophic hormone (ACTH)-secreting 
pituitary cells. 
Conclusions: (-)-llimaquinone inhibits cellular methylations through its 
interactions with S-adenosylhomocysteinase. Furthermore, these studies 
indicate that the inhibition of secretion by ilimaquinone is the result of the 
natural product’s antimethylation activity. It is likely that the ability to fragment 
the Golgi apparatus, as well as other activities, are also related to 
ilimaquinone’s influence on methylation chemistry. 
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Introduction 
The broad range of chemical reactions performed by 
eukaryotes requires extensive compartmentalization of 
the cell. Accompanying this structural complexity is the 
need to communicate between the various spatially segre- 
gated organelles [ l,Z]; the endoplasmic reticulum, Golgi 
apparatus and plasma membrane all exchange their cellu- 
lar cargoes using small, lipid bilayer enclosed vesicles. 
Although the general events of this vesicle-mediated 
transport between the organelles and the cell membrane 
are becoming clearer [3-6], an understanding of the mol- 
ecular machinery involved in regulating vesicle budding 
[7], fission [El], targeting [9,10], docking and fusion [ll-191 
is still largely in question. 
The discovery that the marine sponge metabolite, (-)-ili- 
maquinone [ZO,Zl] (1) selectively breaks down the Golgi 
apparatus into small vesicles blocking cellular secretion in 
a reversible manner provides a unique opportunity for 
studying these important Golgi and endosomal trafficking 
events (Figure lb) [Z&25]. In addition, ilimaquinone has 
been reported to have other interesting biological effects 
including mild antimicrobial, anti-HIV, anti-inflammatory 
and antimitotic activities [26-331, and the inhibition of 
the cytotoxicity of ricin and diphtheria toxin [34]. To 
provide insight into these activities, as well as processes 
regulating vesicle-mediated secretory events, we have 
prepared structural variants of ilimaquinone that could be 
useful for uncovering the cellular interactions of the 
natural product. 
(-)-Ilimaquinone (l), the unnatural enantiomer (+)-ili- 
maquinone (2) and other variants of the natural product 
were prepared through total synthesis (Figure la) [35]. 
By evaluating their antisecretory effects, analogs were 
selected that influence vesicle-mediated processes of the 
Golgi apparatus in a manner similar to the natural 
product [36]. Specifically, compounds 3 and 5 were 
shown to inhibit alkaline phosphatase secretion in 
Jurkat cells at concentrations comparable to 1, whereas 
related compounds in the enantiomeric series (2 and 4) 
demonstrated much less antisecretory activity. This 
dependence of activity on absolute stereochemistry sug- 
gested that the antisecretory activities of 1, 3 and 5 
resulted from direct interactions with specific cellular 
target(s). Furthermore, the protected amine functionality 
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(a) (-)-llimaquinone and related analogs. (b) (-)-llimaquinone’s influence on Golgi structure and function. 
of compound 5 offered a versatile handle for preparing 
reagents that might be useful for identifying the cellular 
targets of the natural product. Through the use of these 
Figure 2 
S-Adenosylmethionine 
synthetase 
\ / RX-H 
/ 
Hd bH 
Methionine S-Adenosylmethionine (SAM) 
Y 
Homocysteine 
Hd bH 
SAdenosylhomocysteine (SAH) 
S-Adenosylhomocysteinase 
Chemistry & Biology 
reagents, we report here our findings on the interactions 
of (-)-ilimaquinone and related analogs with proteins of 
the activated methyl cycle (Figure Z), as well as prelimi- 
nary investigations on the relevance of these interactions 
to vesicle-mediated processes of the Golgi apparatus, 
such as secretion. 
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(a) 1) HCO,H 
5 
Chemistry & Biolog) 
The activated methyl cycle. Syntheses of (a) ilimaquinone affinity resin (6) and (b) control resin (7). 
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Figure 4 
(a) Bovine liver proteins eluted from control 
resin (7) and ilimaquinone resin (6). Samples 
were resolved using 15% sodium dodecyl 
sulfate polyacrylamide gel electrophoresis 
(SDS-PAGE) and visualized through silver 
staining. (b) Representative sequencing data 
of isolated proteins. 
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Results and discussion 
Affinity chromatography reveals cellular targets of 
S-adenosylhomocysteinase 
As shown in Figure 3, treatment of analog 5 with formic 
acid followed by capture of the resulting free amine with 
an activated resin (Affigel-10) afforded the ilimaquinone 
affinity resin 6 (Figure 3a). Similarly, control resin 7 was 
generated from a tethered cyclohexanol derivative 
(Figure 3b). Tissue samples from a variety of sources were 
homogenized and incubated with these ilimaquinone and 
control resins. The resins were then examined for proteins 
that remained bound after extensive washings. 
Figure 4a illustrates a representative example of the 
crude bovine liver proteins that were specifically retained 
on the ilimaquinone resin 6, in comparison with the 
control resin 7. A competition experiment in the presence 
of excess 1 significantly reduced the binding of these pro- 
teins to resin 6. Sequencing of the major bands that were 
selectively observed on the ilimaquinone resin 6 identi- 
fied several known proteins. In addition to some targets 
of undetermined interest (including a polipoprotein Al 
precursor, serum albumin precursor and glutathione-s- 
transferase), three enzymes from the activated methyl 
cycle were isolated (Figure 4b). Specifically, S-adenosyl- 
methionine synthetase (SAM synthetase; EC2.5.1.6) 
[37-40], S-adenosylhomocysteinase (SAHase) [41-43], 
and a protein that might be catechol-O-methyl transferase 
(COMT) [44-47] all bind selectively to the immobilized 
analog resin (6). 
Inhibitors of enzymes of the activated methyl cycle inhibit 
secretion 
Intrigued by the collective role these enzymes play in 
mediating cellular methylations, we examined their rele- 
vance to vesicle trafficking. Specifically, we asked 
whether blocking the function of these enzymes with 
known inhibitors of methylation chemistry will influence 
secretion. We found that cycloleucine and tripolyphos- 
phate both obstruct alkaline phosphatase secretion in 
Jurkat cells [36] at concentrations consistent with their 
known inhibitory affects on SAM synthetase [48,49]. Sim- 
ilarly, as illustrated in Figure 5, S-adenosylhomocysteine 
(SAH), an inhibitor of methyltransferases [50,51], and 
5’-deoxyadenosine, an inhibitor of S-adenosylhomocys- 
teinase [Xl, also block secretion in a concentration 
dependent fashion. These results suggest that, as 
inhibitors of methylation enzymes also influence secre- 
tion, methylation events are involved in some aspect of 
vesicular-mediated secretion. 
Further support for ilimaquinone’s interference with 
methylation being the basis of its antisecretory effects was 
found by examining the influence of the methylating agent 
S-adenosylmethionine (SAM, the product of SAM syn- 
thetase) on secretion in the presence of various antimethy- 
lation and antisecretory agents. As illustrated in Figure 6, 
the addition of SAM to cells treated with tripolyphosphate, 
5’-deoxyadenosine or (-)-ilimaquinone returned some or 
all secretory activity to these cells (control experiments 
Figure 5 
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Secreted levels of alkaline phosphatase the presence of ilimaquinone 
and various inhibitors of methylation. 
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Figure 6 
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Exogenous SAM overrides the inhibitory effects of antimethylation agents 
and ilimaquinone on alkaline phosphatase secretion in Jurkat cells. 
show that SAM does not react with ilimaquinone under the 
assay conditions). On the other hand, cells treated with 
brefeldin A, an unrelated inhibitor of Golgi structure and 
function [53-571, did not recover secretory activity upon 
the addition of SAM. As the antisecretory effects of ili- 
maquinone, as well as the other inhibitors of methylation 
can be reversed by adding the product of the active methyl 
Figure 7 
cycle, SAM, a functional role for methylation in vesicle- 
mediated secretion gains further credibility. 
(-)-llimaquinone inhibits S-adenosylhomocysteinase 
Whether (-)-ilimaquinone has a specific influence on any 
one of the methylation enzymes was addressed next. Activ- 
ity assays for each of the isolated enzymes of the activated 
methyl cycle were examined in the presence and absence 
of the natural product (1). The methyl-transfer activity of 
COMT was not inhibited by ilimaquinone [58] and 1 did 
not serve as a substrate for this enzyme [59]. Although the 
natural product did appear to limit SAM synthetase activity 
in crude liver cytosol [60,61], it did not have a profound 
influence in cytosol derived from the pancreas, brain, 
kidney, heart or pituitary cells, nor did it inhibit the func- 
tion of SAM synthetase isozymes isolated from bovine liver 
(for isolation of SAM synthetase isozymes see [62-641). 
(-)-Ilimaquinone was found to inhibit the SAHase-cat- 
alyzed hydrolysis of S-adenosylhomocysteine (Figure 7a), 
however, in a fashion similar to the known inhibitor, 
5’-deoxyadenosine [65-67]. As illustrated in Figure 7, the 
inactive (+)-chloroquinone analog 4 had little influence on 
the enzyme. Preliminary kinetic analyses indicate that 1 is 
a competitive inhibitor of SAHase; additional studies with 
bovine sources of the enzyme are required, however, to 
confirm this observation [68,69]. 
A consequence of interfering with SAHase should be 
an intracellular accumulation of S-adenosylhomocysteine. 
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(-)-llimaquinone inhibits 
S-adenosylhomocysteinase (SAHase). 
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(-)-llimaquinone (1) hinders new methylations. 
This agent is known to be a potent feedback inhibitor of 
methyl transferases [50,51]. The addition of ilimaquinone 
could. therefore, interfere with new methylation events by 
increasing the intracellular levels of S-adenosylhomocys- 
teine. As shown in Figure 8, mouse adrenocorticotrophic 
hormone (ACTH)-secreting pituitary cells treated for 
1 hour with [3H]-SAM (or [sH]-methionine), in the pres- 
ence of 1, showed a marked reduction of new methyla- 
tions relative to the cells that are exposed to only 
[3H]-SAM. This inhibition was particularly evident within 
the crude membrane fraction. The influence of ilima- 
quinone on SAHase and therefore cellular methylation 
events, as well as the ability of SAM to reverse the natural 
product’s effects on secretion, support a role for methyl- 
ation in mediating cellular secretory events. 
Significance 
We present here several advances in understanding the cel- 
lular activities of the natural product ilimaquinone. The 
ability of ilimaquinone to block secretion is shown to be 
due to its inhibition of methylation chemistry. A connec- 
tion between the natural product’s antisecretory activity 
and its influence on cellular methylation comes in several 
forms. Affinity chromatography experiments show that the 
methylation enzymes Sadenosylmethionine (SAM) syn- 
thetase, Sadenosylhomocysteinase, and possibly catechol- 
Omethyltransferase (COMT) interact either directly or 
indirectly with (-)-ilimaquinone [701. Known inhibitors of 
these methylation enzymes were found to inhibit secretion. 
Moreover, SAM, the cellular methylating agent, reverses 
the antisecretory effects of these inhibitors, as well as ili- 
maquinone. In addition, we show that ilimaquinone 
inhibits the activity of Sadenosylhomocysteinase and dis- 
rupts new methylation events occurring within the cell. 
Although a clearer picture of the cellular activities of ili- 
maquinone is emerging, questions still remain. 
The specific relationship between the natural product’s 
influence on cellular methylations, Golgi morphology and 
vesicle fusion has not been determined 1713. Protein and 
lipid methylation events are known to play a role in 
vesicle-mediated processes 172-741. For example, car- 
boxy1 methylation of the rab family GTPases have been 
implicated as a regulatory step in intracellular vesicular 
trafficking 175771. Determining the effects of (-)-ilima- 
quinone on the methylation state of these proteins could 
provide insight in the natural product’s influence on 
vesicle fusion. Similarly, determining whether SAM 
antagonizes ilimaquinone’s ability to vesiculate the Golgi 
apparatus is another question that remains. Furthermore, 
identifying the methylation event that leads to the inhibi- 
tion of vesicle-mediated secretion and the nature of ili- 
maquinone’s inhibition of Sadenosylhomocysteinase are 
of principal importance. 
The findings detailed above identify Sadenosylhomocys- 
teinase as a cellular target of (-)-ilimaquinone. These 
observations provide a clearer understanding of ilima- 
quinone’s influence on vesicle-mediated processes of the 
cell Moreover, new opportunities for viral infection and 
atherothrombosis therapies might also be possible consid- 
ering the involvement of S-adenosylhomocysteinase in 
these diseases 178-831. 
Materials and methods 
General 
Starting materials and reagents were purchased from commercial sup- 
pliers and used without further purification. CH,CI, and dimethylsulfox- 
ide (DMSO) were distilled over calcium hydride under an atmosphere 
of nitrogen. Methanol and isopropanol were predried over 4 8, sieves. 
Syntheses were carried out under N, or Ar in oven-dried (140% > 4 h) 
glassware. Air- or moisture-sensitive liquids were transferred by syringe 
and were introduced into the reaction flasks through rubber septa. Air- 
or moisture-sensitive solids were transferred in a glove bag under N,. 
Unless otherwise stated, reactions were stirred with a Teflon covered 
stir bar and carried out at room temperature. 3[Hl-Methionine 
(25 Cilmmol) and [8-Ct4]-5’ chlorodeoxyadenosine (250 pCi/mmol) 
were obtained from Movarek Laboratories. Packard Sovable and 
Packard Formula-989 LSC cocktail were obtained from DuPont-New 
England Nuclear. Affigel-10, polyvinylidene difluoride (PVDF) mem- 
brane, and polyprep columns (10 ml) were purchased from BioRad. 
Centrifugation was carried out in a Beckman L-70 Ultracentrifuge using 
a Type 70 Ti rotor. Proteins were separated using SDS-PAGE. Fresh 
tissue samples were obtained from Research 87 (Hopkinton, MA) and 
were homogenized in a Waring Blender. Protein sequencing was per- 
formed by the Harvard Microchemistry Laboratories, Harvard Univer- 
sity, Cambridge, MA. Comparisons of isolated protein sequences to 
known proteins in the SwissProt database were carried out on the 
Computational Biochemistry server at Eidgenbssische Technische 
Hochschule Zurich (ETHZ). 
Preparation of ilimaquinone affinity chromatography resins 
llimaquinone analog 5 (3.0 mg, 5.1 pmol) was dissolved in formic acid 
(88%, 0.10 ml). After 1 h of stirring, the solvent was removed under 
vacuum to yield the amine as a purple oil (2.4 mg, 98%), which was 
used immediately in the subsequent reaction. Affigel-10 (1.2 ml) was 
placed in a poly-prep column and washed with isopropanol (3x bedvol- 
ume). The amine dissolved in DMSO (120 ul) and isopropanol (1.8 ml) 
was added. The slurry was shaken gently at 4°C. After 6 h the resin 
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was filtered and washed with isopropanol (3x bedvolume). The resin 
was then capped with ethanolamine (30 ui) in isopropanol (1.8 ml) for 
2 h at 4°C. The purple ilimaquinone resin 6 was filtered, washed with 
isopropanol (3x bedvolume) and stored in isopropanol at -78’C until 
further use. 
Control resin 7 was prepared as follows. Cyclohexanol (0.217 g, 
2.17 mM), N-BOC-heptanoic acid (0.532 g, 2.6 mmoles), and DMAP 
(0.106 g, 0.87 mmoles) were dissolved in CH,CI, (2.0 ml) and cooled 
to 0°C. EDCI (0.500 g, 2.6 mmoles) dissolved in CH,CI, (3.0 ml) was 
added dropwise to the cooled stirred solution. After the addition was 
complete, the reaction mixture was stirred for another 2 h and then 
allowed to warm up to room temperature. After 12 h the reaction was 
quenched with Ha0 and 50/o HCI and extracted with ether (3x). The 
organic layer was washed with saturated NH&I, brine, dried over 
Na,SO,, and concentrated to yield the tethered cyclohexanol derivative 
as a clear oil (0.35 g, 98%) which was used without further purifica- 
tion. ‘H NMR (CDCI,, 300 MHz) 6 4.75 (1 H, m), 4.51 (1 H, br s), 3.11 
(2H, dt, J=6.1, 6.4 Hz), 2.28 (2H, t, 1=7.3 Hz), 1.83 (3H, m), 1.70 
(4H, m), 1.66-1.49 (6H, m), 1.44 (9H, s), 1.39-1.30 (5H, m); 13C 
NMR (CDCI,, 1OOMHz) 6 207.6, 197.6. 153.7, 156.6, 73.1, 41.0, 
35.2, 32.3, 29.4, 27.1, 26.9, 25.6, 24.4; IR (thin film, NaCI) 3383, 
2936,2861,1722,1527, 1363,1243,1187 cm-‘. 
The tethered cyclohexanol derivative (4.1 mg, 12 pmol) was dissolved 
in formic acid (88%, 0.10 ml). After 1 h of stirring, the solvent was 
removed under vacuum to yield the amine as a green oil (3.0 mg, 
970/o), which was used immediately in the subsequent reaction. 
Affigel-10 (1.5 ml) was placed in a poly-prep column and washed with 
isopropanol (3x bedvolume). The amine dissolved in isopropanol 
(2.0 ml) was added. The slurry was shaken gently at 4’C. After 6 h the 
resin was filtered and washed with isopropanol (3x bedvolume). The 
resin was capped with ethanolamine (30 pl) in isopropanol (2.0 ml) for 
2 h at 4°C. The colorless resin was filtered, washed with isopropanol 
(3x bedvolume) and stored in isopropanol at -78°C until further use. 
General procedure for affinity chromatography 
Calf tissue was cut into cubes (2 cm3) and homogenized in a blender 
(homogenizing buffer: 4 M glycerol, 100 mM piperazine-1,4-his 
(PIPES), 1 mM dithiothreitol (DTT), 2 mM EDTA, 5 pglml pepstatin, 
75 pg/ml phenylmethyl sulfonyl fluoride (PMSF), 2 ug/ml aprotinin, 
2 mglml leupeptin pH 6.9, 1:3 g tissue:ml buffer). The crude extract 
was centrifuged at 48,000 rpm (100,000 x g) for 1.5 h to yield a clear 
supernatant. Aliquots were frozen in liquid nitrogen and stored at 
-78°C until further use. 
Tissue supernatant (6 ml) was incubated with control resin 7 (20 ul) at 
4°C to remove abundant proteins binding indiscriminately to the resin 
and the linker. After 6 h the mixture was filtered. The filtrate was divided 
into two batches: (i) ilimaquinone resin 6 (20 pl) was incubated with 
supernatant (3 ml) and (ii) a control experiment containing control resin 
7 (20 ul) with the remaining supernatant (3 ml). After 12 h the resin of 
each experiment was filtered and washed three times with homogeniz- 
ing buffer (750 pl) for 1 h. The resins were then washed with SDS 
sample buffer (25 ul) to collect the proteins that were still bound to the 
resin. These proteins were separated using SDS-PAGE and visualized 
with Commassie Blue or silver nitrate. 
To obtain sufficient sample for sequencing, liver supernatant (550 ml) 
was incubated with control resin 7 (200 pl) at 4’C to remove abundant 
proteins binding to the resin and the linker. After 6 h the mixture was fil- 
tered. The filtrate was divided into 2 batches: (i) ilimaquinone resin 6 
(100 ul) was incubated with supernatant (500 ml) and (ii) a control 
experiment containing control resin 7 (20 pl) with supernatant (50 ml). 
After 12 h the resin of each experiment was filtered and washed with 
homogenizing buffer (750 ul, 3x) for 1 h. Resins were washed with 
SDS sample buffer (5Of.u) to collect bound proteins. These proteins 
were separated by SDS-PAGE gel electrophoresis and visualized with 
Commassie Blue. 
The SDS-PAGE gel was placed along with a PVDF membrane (PVDF 
membrane is pre-equilibrated in MeOH for 2 min and then washed in 
H,O for 20 min before use) into BioRad blotting apparatus. Protein 
transfer was carried out for 40-l 20 min at 100 V in transfer buffer 
(10% MeOH, 192 mM Tris, 25 mM Gly). After protein transfer, PVDF 
membrane was stained with Panceau (1% Panceau, 3% acetic acid) 
and subsequently washed with H,O (10 ml). Stained protein bands 
were cut out and again washed with H,O (2 ml). The membranes 
were stored at -20°C until sequencing. Several proteins were 
sequenced directly from the polyacrylamide gel. Here, the protein 
bands were cut out of the gel and washed with 500/o CH,CN (1 ml, 
2x) for 10 min. After washings, the protein bands were stored at 
-20°C until sequenced. 
Evaluation of methylation inhibitors on secretory activity 
All plasticware and glassware were pre-sterilized or purchased sterile. 
Cell culture media was filtered through Nalgene sterile filters with 
0.2 urn nylon membrane filters before use. The plasmid encoding for 
secreted alkaline phosphatase was obtained from the Schreiber labora- 
tory at Harvard University and used with permission. Incubation refers 
to storing cells in tissue culture flasks with canted necks and vent caps 
in a CO, incubator at 37”C, 5.0% CO, and 100% humidity. Centrifu- 
gation, pelleting, or spinning down refers to using a swinging bucket 
centrifuge at room temperature at 1000 rpm (165 x g) for 10 min then 
aspirating the spent media. Ceil counts were obtained using a hemacy- 
tometer with cells stained with trypan blue (0.40/o), counts were done in 
duplicate and averaged. Cell morphology was monitored using a 
phase-contrast cell culture light microscope at 40x. 
Jurkat cells were incubated in RPMI 1640 media (without phenol red), 
10% fetal bovine serum (FBS), and 5% penicillin/streptomycin. For 
normal cell maintenance, cells were grown until saturation 
(1.5-2.5 x 1 O6 cells/ml), then diluted tenfold with fresh media. To run 
the assay, 1 x 1 O7 cells were pelleted. (Amount required for two com- 
pounds assayed in duplicate). Cells were rinsed with RPMI 1640 
media and resuspended in 500 pl of RPMI 1640 media. The cells were 
pipetted into a 4 mm cuvette containing plasmid (20 pg). Equilibration 
(20 min, room temperature), was then followed by electroporation 
(960 uF, 300 V, room temperature). The cells were reequilibrated 
(20 min, room temperature), then diluted with unselected media 
(10.0 ml, RPMI 1640, 10% FBS) and incubated for 48 h. Under these 
conditions, a 50% viability of cells was obtained. The cells were then 
pelleted and resuspended in fresh media (4 ml, RPMI 1640, 10% FBS, 
5% penicillin/streptomycin). 
Compounds to be tested for effects on secretion were introduced in a 
range of concentrations into 98-well plates. Unactivated cells (100 1.11, 
1.2 x 1 O6 cells/ml) were pipetted into the wells. To activate the cells for 
alkaline phosphatase secretion, ionomycin and phorbol myristate 
acetate (PMA) (to a 2 pM and 100 rig/ml concentration, respectively) 
were added. The total volume in each well was diluted to 200 ml with 
fresh media. The plate was incubated overnight (37’C, 5% CO,, 100% 
humidity) and then heated (68”C, 1.5 h) to denature heat-sensitive 
phosphatases. A p-nitrophenylphosphate solution (100 ul, 1 mglml of 
p-nitrophenylphosphate in 2 M diethanolamine bicarbonate, pH 10.0) 
was added to the wells of a new plate. The heat-treated cells and 
media (100 ul) were added to the corresponding p-nitrophenylphos- 
phate-containing wells and incubated for 12-24 h. The absorption 
(410 nm) of each well was measured using a microplate spectropho- 
tometer. Compounds tested include: cycloleucine, tripolyphosphate, 
5’-deoxyadenosine, S-adenosylhomocysteine, (+)-ilimaquinone, (-)-ili- 
maquinone and brefeldin A. 
Secretion assay in the presence of SAM 
The methylation inhibitors were introduced into the 96-well plate in the 
following concentrations: (-)-ilimaquinone (50 PM), tripolyphosphate 
(1 .O mM), S-adenosylhomocysteine (2.0 mM), 5’-deoxyadenosine 
(1 .O mM), (+)-ilimaquinone (0.1 mM) and brefeldin A (5 PM). A range of 
SAM concentrations (6 uM-25 mM) were also added into the 96swell 
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plates containing the methylation inhibitor. The secretion assay was 
then run as described above. 
Effects of ilimaquinone on enzymes of the activated methyl 
cycle (SAM synthetase) 
SAM synthetase activity was measured using either crude bovine liver 
cytosol or purified isoforms from bovine liver. The samples (50 pl) were 
diluted with assay buffer (300 mM KCI, 15 mM MgSO,, 4 mM DlT, 
100 mM HEPES, 10 mM ATP, [sH]-methionine (0.75 pg, 5 pmol, 
0.25 pCi), pH 7.5) to yield a total volume of 100 ~1. The reaction mix- 
tures were incubated at 37X. Enzyme dilution was adjusted so that no 
more than 20% of [3H]-methionine was converted to SAM. After 1 h, 
80 pl of the reaction mixture was spotted on a Whatman P-81 phos- 
phocellulose disk and placed in ammonium formate (0.1 M, 10 ml). The 
ammonium formate was decanted and the disk was washed with 
ammonium formate (0.1 M, 10 ml), ethanol (10 ml), and diethyl ether 
(10 ml). The disk was allowed to air dry and the amount of SAM pro- 
duced was determined through scintillation methods. This procedure 
was carried out in the presence and absence of several inhibitors such 
as (-)-ilimaquinone, (+)-ilimaquinone, 5’-deoxyadenosine and S-adeno- 
sylhomocysteinase at various concentrations. 
Catechol-0-methyltransferase 
COMT was assayed with slight modifications to the procedure of Rivett 
et al. [56]. Buffer A (2.5 mM MgCI,, 1 .O mM paraglyine, 1 .O mM SAM, 
4.0 FM, 1.5 x lo4 cpm/nM dopamine) was prepared (total volume 
4 ml) and 300 @I was added by pipette into six separate 1.5 ml eppen- 
dorfs. llimaquinone (0.625 pl, 0.04 M) was added by pipette into two of 
the eppendorfs, pyrogallol (0.625 pl, 5 mM) into another two eppen- 
dorfs, and double-distilled water (ddw 0.625 VI) were added by pipette 
into the last two. The solutions were incubated (37”C, 100% humidity, 
5% CO,, 40 min) The reactions were terminated with potassium borate 
(1 ml, 0.05 M). Methylated dopamine was isolated by extraction 
(3:2 toluenelisoamyl alcohol, 5 ml). The mixture was vortexed for 15 s 
and centrifuged (600 x g, 5 min). An aliquot (1 ml) of the organic phase 
was added to scintillation fluid (5 ml). Radioactivity of the methylated 
dopamine was quantified by liquid scintillation methods. 
S-adenosylhomocysteinase 
[8-14CI-S-Adenosylhomocysteine (5.2 pg, 14 nM, 12 @) was incu- 
bated in the presence of enzyme (0.5 pg) at 37’C for 15 min in a total 
reaction volume of 0.1 ml. The incubation buffer was 15 mM Hepes, 
5 mM Mg(OAc),, 150 mM KCI, 2 mM 2-mercaptoethanol, 0.25% 
bovine serum albumin, pH 7.0 including adenosine deaminase 
(50 units/ml). The incubations were stopped by the addition of formic 
acid (5 N, 0.1 ml) and the reaction mixture was poured onto a SP- 
SephadexC25 column (50 mm x 150 mm) pre-equilibrated with 0.1 N 
formic acid. [14C]-lnosine was eluted with formic acid (0.1 N, 1.5 ml) 
and collected in a scintillation vial with scintillation fluid (5 ml). Inhibitors 
such as (-)-ilimaquinone, 5’7deoxyadenosine, (+)-chloroquinone, 
methionine and S-adenosylhomocysteine were added to assay at con- 
centrations ranging between 0.05-l .O mM. 
Ilimaquinone’s influence on new methylations 
Cells (2.7 x 107) were pelleted, rinsed with methionine-free F12K 
media, repelleted and suspended in 1.9 ml methionine-free F12K 
media. Tritiated SAM (100 pl, 2.6 l.0, 10 Cilmmole) was added to 
the cell suspension (1.9 ml, 1.4 x 1 O7 cells/ml). (-)-llimaquinone 
(0.63 pl, 0.04 M) was then pipetted into two sterile eppendorfs, 
whereas ddw (0.63 ~1) was pipetted into another two eppendorfs. 
After several minutes, equal amounts of radiolabeled cell suspension 
(500~1, 1.4 x 107 cells/ml) were pipetted into the four eppendorfs 
and mixed thoroughly. All solutions were warmed (1 h, 37X, 5% CO,, 
100% humidity) and shaken every 15 min. After the incubation was 
complete, nonincorporated SAM was removed via centrifugation 
(100 x g, 4’C, 10 min). Supernatant was removed and counted to 
quantify amount of nonincorporated SAM. The cellular pellet was 
lysed with 2 ml of lysis buffer (3.0 M MgCI,, 7.6 mM TrisCI, 1 .l mM 
P-mercaptoethanol pH 7.6; titrated with HCI). Lysis was carried out 
with 100 strokes in a glass homogenizer. Lysed cells were removed 
and the homogenizer was rinsed (3x) with ddw (1 ml) and the cell sus- 
pension (5 ml total) was placed in a polypropylene ultracentrifuge 
tube. The following protease inhibitors were used during the lysis and 
throughout the remainder of the assay and for storage purposes: lysis 
buffer with 2.9 pM pepstatin-A, 2.1 PM leupeptin, 1 .O mgll aprotinin, 
2.0 mM EDTA, 0.43 M PMSF. Ultracentrifugation (15,000 x g, 4X, 
30 min) was carried out to remove unbroken debris, mitochondria and 
lysosomes. The supernatant was pipetted into a clean ultracentrifuge 
tube and pelleted (100,000 x g, 4”C, 60 min) to separate the cytosol 
from the membranes. The pellet from previous centrifugation was dis- 
solved and counted. Membrane and cytosol were separated and 
crude counts were measured. Scintillation techniques were used to 
count 1 Oo/, of the total volume of a solution. 
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